Imunon, Inc. (IMNN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US15117N7012
Imunon, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -14.65 m USD |
| EBIT | -14.50 m USD |
| Net income | -14.50 m USD |
| Diluted EPS – continuing operations | -6.83 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Imunon, Inc.
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. In addition, the company develops non-viral DNA technology across modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.
More stocks
- Perfect Moment Ltd. (PMNT)
- Global Innovative Platforms Inc. (GIPL)
- GHST World Inc. (GHST)
- International Land Alliance Inc. (ILAL)
- Cyngn Inc. (CYN)
- Trevi Finanziaria Industriale SpA (TFIN.MI)
- Sports Entertainment Gaming Global Corp (SEGG)
- Azitra, Inc. (AZTR)
- DYNAMIC AEROSPACE SYSTEMS Corp (BRQL)
- New Concept Energy, Inc. (GBR)
- NAPC Defense, Inc. (NAPD)
- Longeveron Inc. (LGVN)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.